Atrial fibrillation: Pathogenesis, medical-surgical management and dental implications

Journal of the American Dental Association

Volumn 140, Issue 2, 2009, Pages 167-177

  Friedlander, Arthur H ^a   Yoshikawa, Thomas T ^b   Chang, Donald S ^b   Feliciano, Zenaida ^b   Scully, Crispian ^c  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Anticoagulation therapy; Cardiovascular diseases; Stroke

Indexed keywords

EID: 60449094255     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2009.0130     Document Type: Review

References (90)

1. Raghavan AV, Decker WW, Meloy TD. Management of atrial fibrillation in the emergency department. Emerg Med Clin North Am 2005;23(4):1127-1139.
2. Tagawa M, Takeuchi S, Chinushi M, et al. Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism. Pacing Clin Electrophysiol 2007;30(9):1121-1128.
3. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348(13):1215-1222.
4. Miyasaka Y, Barnes MF, Petersen RC, et al. Risk of dementia in stroke-free patients diagnosed with atrial fibrillation: data from a community-based cohort. Eur Heart J 2007;28(16):1962-1967.
5. Go AS. The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg. Am J Geriatr Cardiol 2005;14(2):56-61.
6. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994;74(3):236-241.
7. Lakshminarayan K, Anderson DC, Herzog CA, Qureshi AI. Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist 2008;14(3):143-150.
8. Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics: 2007 update - a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115(5):e69-e171.
9. Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000;35(6):1628-1637.
10. Friberg L, Hammar N, Pettersson H, Rosenqvist M. Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial fibrillation (SCAF). Eur Heart J 2007;28(19):2346-2353.
11. Lip GY, Tse HF. Management of atrial fibrillation. Lancet 2007;370(9587):604-618.
12. Miyasaka Y, Barnes ME, Gersh BJ, et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006;114(2):119-125.
13. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA 2004;292(20):2471-2477.
14. Tsang TS, Miyasaka Y, Barnes ME, Gersh BJ. Epidemiological profile of atrial fibrillation: a contemporary perspective. Prog Cardiovasc Dis 2005;48(1):1-8.
15. Saffitz JE. Connexins, conduction, and atrial fibrillation. N Engl J Med 2006;354(25):2712-2714.
16. Vergara P, Picardi G, Nigro G, et al. Evaluation of thyroid dysfunction in patients with paroxysmal atrial fibrillation. Anadolu Kardiyol Derg 2007;7(suppl 1):104-106.
17. Falk RH. Atrial fibrillation. N Engl J Med 2001;344(14):1067-1078.
18. Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007;69(6):546-554.
19. Haïssaguerre M, Jaïs P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339(10):659-666.
20. Gillinov AM, Wolf RK. Surgical ablation of atrial fibrillation. Prog Cardiovasc Dis 2005;48(3):169-177.
21. Cooke G, Doust J, Sanders S. Is pulse palpation helpful in detecting atrial fibrillation? A systematic review. J Fam Pract 2006;55(2):130-134.
22. Van Gelder IC, Hagens VE, Bosker HA, et al. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347(23):1834-1840.
23. National Collaborating Centre for Chronic Conditions. Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care. London: Royal College of Physicians; 2006.
24. Snow V, Weiss KB, LeFevre M, et al; AAFP Panel on Atrial Fibrillation; ACP Panel on Atrial Fibrillation. Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians. Ann Intern Med 2003;139(12):1009-1017.
25. Goldstein LB, Adams R, Alberts MJ, et al; American Heart Association; American Stroke Association Stroke Council. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council; Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group (published correction appears in Circulation 2006;114[22]:e617). Circulation 2006;113(24):e873-e923.
26. Saxena R, Koudstaal PJ. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack. Cochrane Database Syst Rev 2004;(4):CD000187.
27. Fang MC, Go AS, Chang Y, et al. Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med 2007;120(8):700-705.
28. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146(12):857-867.
29. Schauer DP, Moomaw CJ, Wess M, Webb T, Eckman MH. Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. J Gen Intern Med 2005;20(12):1114-1119.
30. Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM. Optimizing the use of antithrombic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention. J Am Geriatr Soc 2005;53(11):1912-1920.
31. Mead GE, Elder AT, Flapan AD, Kelman A. Electrical cardioversion for atrial fibrillation and flutter. Cochrane Database Syst Rev 2005;(3):CD002903.
32. Wyse DG. Rate control vs. rhythm control strategies in atrial fibrillation. Prog Cardiovasc Dis 2005;48(2):125-138.
33. Ziv O, Choudhary G. Atrial fibrillation. Prim Care 2005;32(4):1083-1107.
34. Singh BN, Singh SN, Reda DJ, et al; Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T) Investigators. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med 2005;352(18):1861-1872.
35. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation for the Cure of Atrial Fibrillation Study). Eur Heart J 2006;27(2):216-221.
36. Wisser W, Seebacher G, Fleck T, et al. Permanent chronic atrial fibrillation: is pulmonary vein isolation alone enough? Ann Thorac Surg 2007;84(4):1151-1157.
37. Miller CS, Leonelli FM, Latham E. Selective interference with pacemaker activity by electrical dental devices. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(1):33-36.
38. Drisko CL, Cochran DL, Blieden T, et al. Position paper: sonic and ultrasonic sealers in periodontics. Research, Science and Therapy Committee of the American Academy of Periodontology. J Periodentol 2000;71(11):1792-1801.
39. Patel D, Glick M, Lessard E, Zaim S. Absence of in vivo effects of dental instruments on pacemaker function. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99(4):430.
40. Brand HS, van der Hoeff EV, Schrama TA, Entjes ML, van Nieuw AA. Electromagnetic interference of electrical dental equipment with cardiac pacemakers [in Dutch]. Ned Tijdschr Tandheelkd 2007;114(7):373-376.
41. Niehaus M, Tebbenjohanns J. Electromagnetic interference in patients with implanted pacemakers or cardioverter-defibrillators. Heart 2001;86(3):246-248.
42. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part II: pacing Clin Electrophysiol 2002;25(10):1496-1509.
43. Dawes JC, Mahabir RC, Hillier K, Cassidy M, de Haas W, Gillis AM. Electrosurgery in patients with pacemakers/implanted cardioverter defibrillators. Ann Plast Surg 2006;57(1):33-36.
44. Lockhart PB, Gibson J, Pond SH, Leitch J. Dental management considerations for the patient with an acquired coagulopathy, part 2: coagulopathies from drugs. Br Dent J 2003;195(9):495-501.
45. Lip GY. Post-stenting antithrombotic drug therapy in patients with atrial fibrillation. Am J Med 2007;120(11):920-922.
46. Fuster V, Ryden LE, Cannom DS, et al; and the American College of Cardiology/American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) - developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society (published correction appears in Circulation 2007;116[6]:e138). Circulation 2006;114(7):e257-e354.
47. Jeske AH, Suchko GD. Lack of a scientific basis for routine discontinuation of oral anticoagulation therapy before dental treatment. JADA 2003;134(11):1492-1497.
48. Perry DJ, Noakes TJ, Helliwell PS. Guidelines for the management of patients on oral anticoagulants requiring dental surgery. Br Dent J 2007;203(7):389-393.
49. Devani P, Lavery KM, Howell CJ. Dental extractions in patients on warfarin: is alteration of anticoagulant regime necessary? Br J Oral Maxillofac Surg 1998;36(2):107-111.
50. Wahl MJ. Myths of dental surgery in patients receiving anticoagulant therapy. JADA 2000;131(1):77-81.
51. Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med 1998;158(15):1610-1616.
52. Campbell JH, Alvarado F, Murray RA. Anticoagulation and minor oral surgery: should the anticoagulation regimen be altered? J Oral Maxillofac Surg 2000;58(2):131-136.
53. Evans IL, Sayers MS, Gibbons AJ, Price G, Snooks H, Sugar AW. Can warfarin be continued during dental extraction? Results of a randomized controlled trial. Br J Oral Maxilliofac Surg 2002;40(3):248-252.
54. Sacco R, Sacco M, Carpenedo M, Moia M. Oral surgery in patients on oral anticoagulant therapy: a randomized comparison of different INR targets. J Thromb Haemost 2006:4(3):688-689.
55. Al-Mubarak S, Rass MA, Alsuwyed A, Alabdulaaly A, Ciancio S. Thromboembolic risk and bleeding in patients maintaining or stopping oral anticoagulant therapy during dental extraction. J Thromb Haemost 2006;4(3):689-691.
56. Beirne OR. Evidence to continue oral anticoagulant therapy for ambulatory oral surgery. J Oral Maxillofac Surg 2005;63(4):540-545.
57. Ward BB, Smith MH. Dentoalveolar procedures for the anticoagulated patient: literature recommendations versus current practice. J Oral Maxilliofac Surg 2007;65(8):1454-1460.
58. Scully C, Wolff A. Oral surgery in patients on anticoagulated therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94(1):57-64.
59. Ferrieri GB, Castiglioni S, Carmagnola D, Cargnel M, Strohmenger L, Abati S. Oral surgery in patients on anticoagulant therapy without treatment interruption. J Oral Maxillofac Surg 2007;65(6):1149-1154.
60. Aframian DJ, Lalla RV, Peterson DE. Management of dental patients taking common hemostasis-altering medications. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;103(suppl):S45.e1-S45.e11.
61. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest 2001;119(1 suppl):22S-38S.
62. Kistler PM. Management of atrial fibrillation. Aust Fam Physician 2007;36(7):506-511.
63. Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ. Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin. Ann Intern Med 2001;135(6):393-400.
64. Pêrez-Gômez F, Iriarte JA, Zumalde J, et al. Antithrombotic therapy in elderly patients with atrial fibrillation: effects and bleeding complications: a stratified analysis of the NASPEAF randomized trial. Eur Heart J 2007;28(8):996-1003.
65. Wittkowsky AK, Whitely KS, Devine EB, Nutescu E. Effect of age on international normalized ratio at the time of major bleeding in patients treated with warfarin. Pharmacotherapy 2004;24(5):600-605.
66. Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004;147(1):3-15.
67. Douketis JD. Perioperative anticoagulation management in patients who are receiving oral anticoagulant therapy: a practical guide for clinicians. Thromb Res 2002;108(1):3-13.
68. Jaffer AK. Anticoagulant management strategies for patients on warfarin who need surgery. Cleve Clin J Med 2006;73(suppl 1):S100-S105.
69. Woods K, Douketis JD, Kathirgamanathan K, Yi Q, Crowther MA. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. J Thromb Thrombolysis 2007;24(2):93-97.
70. Lessard E, Glick M, Ahmed S, Saric M. The patient with a heart murmur: evaluation, assessment and dental considerations. JADA 2005;136(3):347-356.
71. Shireman TI, Howard PA, Kresowik TF, Ellerbeck EF. Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients. Stroke 2004;35(10):2362-2367.
72. Hersh EV. Adverse drug interactions in dental practice: interactions involving antibiotics. Part II of a series. JADA 1999;130(2):236-251.
73. Delaney JA, Opatrny L, Brophy JM, Suissa S. Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 2007;177(4):347-351.
74. Juurlink DN. Drug interactions with warfarin: what clinicians need to know. CMAJ 2007;177(4):369-371.
75. Hart RG, Tonarelli SB, Pearce LA. Avoiding central nervous system bleeding during antithrombotic therapy: recent data ideas. Stroke 2005;36(7):1588-1593.
76. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 1998;279(9):657-662.
77. Thijssen HH, Soute BA, Vervoort LM, Classens JG. Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle. Thromb Haemost 2004;92(4):797-802.
78. Conly JM, Stein K, Worobetz I, Rutledge-Harding S. The contribution of vitamin K2 (menaquiones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol 1994;89(6):915-923.
79. Davydov L, Yermolnik M, Cuni LJ. Warfarin and amoxicillin/ clavulanate drug interaction. Ann Pharmacother 2003;37(3):367-370.
80. Bharat V, Mohanty B. Bleeding complication during coumarin therapy due to amiodarone and azithromycin. J Assoc Physicians India 2000;48(7):746-747.
81. Caraco Y, Rubinow A. Enhanced anticoagulant effect of coumarin derivatives induced by doxycycline coadministration. Ann Pharmacother 1992;26(9):1084-1086.
82. Penning-van Beest FJ, van Meegen E, Rosendaal FR, Stricker BH. Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs. Clin Pharmacol Ther 2001;69(6):451-457.
83. Holbrook AM, Pereira JA, Labiris R, et al. Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 2005;165(10):1095-1106.
84. Takahashi H, Echizen H. Pharmacogenetics of warfarin elimination and its clinical implications. Clin Pharmacokinet 2001;40(8): 587-603.
85. Pemberton MN, Oliver RJ, Theaker ED. Miconazole oral gel and drug interactions. Br Dent J 2004;196(9):529-531.
86. Chugani V. Management of dental patients on warfarin therapy in a primary care setting. Dent Update 2004;31(7):379-382, 384.
87. Rice PJ, Perry RJ, Afzal Z, Stockley IH. Antibacterial prescribing and warfarin: a review. Br Dent J 2003;194(8):411-415.
88. Yagiela JA, Dowd FJ, Neidle EA, eds. Pharmacology and Therapeutics for Dentistry. 5th ed. St. Louis: Mosby; 2004:517-524.
89. Scully C, Ettinger RL. The influence of systemic diseases on oral health care in older adults (published correction appears in JADA 2008;139[3]:252-253). JADA 2007;138:(suppl):7S-14S.
90. Scully C, Diz Dios P, Kumar N. Special Care in Dentistry: Handbook of Oral Health Care. Edinburgh, England: Churchill Livingstone; 2007.